A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions

All of RECERCAT

To access the full text documents, please follow this link: http://hdl.handle.net/2445/107753

Title:	A budget impact analysis of Spiromax compared with Turbuhaler for the treatment of moderate to severe asthma: a potential improvement in the inhalation technique to strengthen medication adherence could represent savings for the Spanish Healthcare System and five Spanish regions
Author:	Darbà, Josep; Ramírez, Gabriela; García-Rivero, Juan L.; Mayoralas, Sagrario; Pascual, José Francisco; Roger, Albert; Vargas, Diego; Bijedic, Adi
Other authors:	Universitat de Barcelona
Abstract:	To assess the economic impact of the introduction of DuoResp(®) Spiromax(®) by focusing on a potential improvement in the inhalation technique to strengthen medication adherence for the treatment of moderate to severe asthmatics in Spain and five Spanish regions including Andalusia, Catalonia, Galicia, Madrid, and Valencia. ...
Subject(s):	-Administració de medicaments -Asma -Malalties pulmonars obstructives cròniques -Tractament tèrmic -Economia de la salut -Administration of drugs -Asthma -Chronic obstructive pulmonary diseases -Heat treatment -Medical economics
Rights:	cc-by-nc (c) Darbà, Josep et al., 2016 http://creativecommons.org/licenses/by-nc/3.0/es
Document type:	Article Article - Published version
Published by:	Dove Medical Press
Share: